BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10589910)

  • 1. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review.
    Hernández-Pérez J; Yebra-Bango M; Jiménez-Martínez E; Sanz-Moreno C; Cuervas-Mons V; Alonso Pulpón L; Ramos-Martínez A; Fernández-Fernández J
    Clin Infect Dis; 1999 Oct; 29(4):918-21. PubMed ID: 10589910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral leishmaniasis (kala-azar) in Fars Province, Iran: study of 130 cases.
    Hashemi-Nasab A; Zadeh-Shirazi H
    J Trop Med Hyg; 1980 Jun; 83(3):119-22. PubMed ID: 7401218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deaths in visceral leishmaniasis (Kala-azar) during treatment.
    Ahasan HA; Chowdhury MA; Azhar MA; Rafiqueuddin AK; Azad KA
    Med J Malaysia; 1996 Mar; 51(1):29-32. PubMed ID: 10967976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management.
    Veroux M; Corona D; Giuffrida G; Cacopardo B; Sinagra N; Tallarita T; Giaquinta A; Zerbo D; Veroux PF
    Transpl Infect Dis; 2010 Oct; 12(5):387-91. PubMed ID: 20534033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Visceral leishmaniasis (kala-azar)].
    Berentsen S; Langholm R; Reitan O
    Tidsskr Nor Laegeforen; 1990 Nov; 110(27):3491-3. PubMed ID: 2256078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review.
    Berenguer J; Gómez-Campderá F; Padilla B; Rodríguez-Ferrero M; Anaya F; Moreno S; Valderrábano F
    Transplantation; 1998 May; 65(10):1401-4. PubMed ID: 9625028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of kala-azar associated with post-kala-azar dermal leishmaniasis.
    Sen Gupta PC; Mukherjee AM
    J Indian Med Assoc; 1968 Jan; 50(1):1-5 passim. PubMed ID: 5668350
    [No Abstract]   [Full Text] [Related]  

  • 12. [3 cases of visceral leishmaniasis, one in a HIV-positive man].
    Balslev U; Jonsbo F; Junge J; Bentsen KD
    Ugeskr Laeger; 1991 May; 153(22):1591-2. PubMed ID: 2058021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmaniasis, an emerging imported infection: report of 20 cases from Australia.
    Stark D; van Hal S; Lee R; Marriott D; Harkness J
    J Travel Med; 2008; 15(5):351-4. PubMed ID: 19006509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocardiosis following solid organ transplantation: a single-centre experience.
    Wiesmayr S; Stelzmueller I; Tabarelli W; Bargehr D; Graziadei I; Freund M; Ladurner R; Steurer W; Geltner C; Mark W; Margreiter R; Bonatti H
    Transpl Int; 2005 Sep; 18(9):1048-53. PubMed ID: 16101725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kala-azar comes to New York.
    Parkas V; Godwin J; Murray HW
    Arch Intern Med; 1997 Apr; 157(8):921-3. PubMed ID: 9129553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature.
    Basset D; Faraut F; Marty P; Dereure J; Rosenthal E; Mary C; Pratlong F; Lachaud L; Bastien P; Dedet JP
    Microbes Infect; 2005 Oct; 7(13):1370-5. PubMed ID: 16046170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral leishmaniasis in renal transplant recipients: clinical aspects, diagnostic problems, and response to treatment.
    Oliveira CM; Oliveira ML; Andrade SC; Girão ES; Ponte CN; Mota MU; Fernandes PF; Campos HH; Esmeraldo RM; Evangelista JB
    Transplant Proc; 2008 Apr; 40(3):755-60. PubMed ID: 18455008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy in kala-azar.
    Rees PH; Kager PA; Kyambi JM; Ayim EN; Bhatt KM; Schattenkerk JK
    Trop Geogr Med; 1984 Sep; 36(3):285-92. PubMed ID: 6506208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kala-azar imported from Yugoslavia].
    Rast HP; Marti HR
    Schweiz Med Wochenschr; 1986 Feb; 116(8):252-4. PubMed ID: 3006237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.